Todd Broder, MD
Psychiatry · St Augustine, FLNPI 1699849349
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,116,745 of the $1,588,618 with a category attached, or 70.3%. 18 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 25.0% of the total. 2025 is the largest year on record at $422,655, 4.1 times the $102,681 reported in 2019. Among psychiatry clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 2,341 payments — averaging $678.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$397K
- Johnson & Johnson$396K
- Axsome Therapeutics, Inc.$342K
- AbbVie$217K
- E.r. Squibb & Sons, L.L.C.$124K
- Alkermes, Inc.$62K
- plus $52K from 12 others
Across 36 payments — averaging $2888.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$98K
- Neurocrine Biosciences, Inc.$6K
What the payments were for
- Consulting fees$209,41113%
- Speaking & faculty fees$1,116,74570%
- Travel & lodging$216,34214%
- Food & beverage$46,0553%
- Education$660%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 721 | $396,512 |
| Johnson & Johnson | 590 | $395,824 |
| Axsome Therapeutics, Inc. | 443 | $341,914 |
| AbbVie(2 entities) | 260 | $216,835 |
| E.r. Squibb & Sons, L.L.C. | 139 | $123,764 |
| Alkermes, Inc. | 107 | $61,627 |
| H. Lundbeck A S | 22 | $46,277 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 9 | $2,439 |
| Neuronetics, Inc. | 5 | $1,376 |
| Livanova USA, Inc. | 11 | $684 |
| Neurocrine Biosciences, Inc. | 10 | $501 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $450 |
| Vanda Pharmaceuticals Inc. | 1 | $105 |
| Idorsia Pharmaceuticals US Inc | 1 | $101 |
| Teva Pharmaceuticals USA, Inc. | 4 | $96 |
| Lundbeck LLC | 2 | $54 |
| Sage Therapeutics, LLC | 1 | $35 |
| Indivior Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABILIFY MAINTENA$408,315
- SPRAVATO$387,145
- Auvelity$333,249
- LYBALVI$236,078
- VRAYLAR$212,059
- ABILIFY ASIMTUFII$115,399
- COBENFY$113,860
- REXULTI$17,392
- ARISTADA$2,461
- NEUROSTAR TMS THERAPY$1,230
- VNS - Symmetry$509
- ARISTADA INITIO$486
- INGREZZA$265
- CAPLYTA$236
- INVEGA SUSTENNA$139
- Fanapt$105
- QUVIVIQ$101
How this compares
$1,588,618 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in St Augustine
- Andrew CutlerLakewood Ranch$5.7M
- Richard JacksonBoca Raton$3.6M
- Ilan MelnickCoral Gables$2.8M
- Heather LuingSaint Augustine$1.5M
- Todd GatesWest Melbourne$1.2M
- Lawrence ReccoppaGainesville$968K
- Thomas ValenteLeesburg$967K
- Michelle ScargleClearwater$926K
- David SheehanTampa$631K
- Jose GamezHialeah$557K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.